Clinical Trial Update: Identification of Breath Biomarkers in Head and Neck Squamous Cell Carcinoma

View source ↗

Summary

A clinical trial evaluating breath biomarkers for head and neck squamous cell carcinoma (NCT02156180) is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Cavity Squamous Cell Carcinoma
• Oropharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: Queensland Centre of Excellence for Head and Neck Cancer | Conditions: Oral Cavity Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma | Status: SUSPENDED